ENVB Enveric Biosciences, Inc.
Healthcare$2.23+0.91%ClosedMarket Cap: $1.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.66
P/S
0.00
EV/EBITDA
0.45
DCF Value
$12.40
FCF Yield
-606.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-221.0%
ROA
-148.9%
ROIC
-162.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-1.6M | $-1.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.2M | $-2.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-8.8M | $-12.1M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.9M | $-1.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.5M | $-2.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.2M | $-2.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.2M | $-3.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-9.6M | $-9.6M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-2.1M | $-2.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.9M | $-1.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.5M | $-2.5M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.4M | $-3.4M | $-33.51 | — |